Are high coronary risk patients missing out on lipid-lowering drugs in Australia?

Authors: Leon A Simons and Eric Chung
Medical Journal Australia 2014; 201: 213-216

Related articles

Real world use of antipsychotic medication

A recent publication using Prospections real world data analytics shows, 1 in 5 Australian patients with schizophrenia [1], is medicated with older typical long acting injectable (LAI) antipsychotics. With schizophrenia being one of the ...

A retrospective review of the persistence ...

Aim: To describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients, and assess the influence of methotrexate and other conventional DMARD (cDMARD) concomitant me...

Patterns of Antipsychotic Medication Presc...

Schizophrenia is a mental health disorder characterised by hallucinations, delusions and disorganised behaviour. The Australian pharmaceutical benefits scheme (PBS) reimburse a number of antipsychotic therapies, however, there is little...
This site is registered on wpml.org as a development site.